These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 1718619)
41. Expression and immune recognition of SV40 Tag in transgenic mice that develop metastatic osteosarcomas. Marton I; Johnson SE; Damjanov I; Currier KS; Sundberg JP; Knowles BB Transgenic Res; 2000 Apr; 9(2):115-25. PubMed ID: 10951695 [TBL] [Abstract][Full Text] [Related]
42. Multiple neuroendocrine tumours in transgenic mice induced by c-kit-SV40 T antigen fusion genes. Bossé P; Bernex F; De Sepulveda P; Salaün P; Panthier JJ Oncogene; 1997 Jun; 14(22):2661-70. PubMed ID: 9178764 [TBL] [Abstract][Full Text] [Related]
43. Disruption of thymocyte development and lymphomagenesis induced by SV40 T-antigen. Garvin AM; Abraham KM; Forbush KA; Farr AG; Davison BL; Perlmutter RM Int Immunol; 1990; 2(2):173-80. PubMed ID: 1965144 [TBL] [Abstract][Full Text] [Related]
44. Time-course development of differentiated hepatocarcinoma and lung metastasis in transgenic mice. Dubois N; Bennoun M; Allemand I; Molina T; Grimber G; Daudet-Monsac M; Abelanet R; Briand P J Hepatol; 1991 Sep; 13(2):227-39. PubMed ID: 1660504 [TBL] [Abstract][Full Text] [Related]
45. Alterations of the thymic selection process in transgenic mice expressing SV40 large T antigen. Lee WH; Seo JS Int J Cancer; 1996 Jul; 67(3):399-404. PubMed ID: 8707415 [TBL] [Abstract][Full Text] [Related]
46. Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice. Pasquinelli C; Bhavani K; Chisari FV Cancer Res; 1992 May; 52(10):2823-9. PubMed ID: 1316229 [TBL] [Abstract][Full Text] [Related]
48. Transgenic TIMP-1 inhibits simian virus 40 T antigen-induced hepatocarcinogenesis by impairment of hepatocellular proliferation and tumor angiogenesis. Martin DC; Sanchez-Sweatman OH; Ho AT; Inderdeo DS; Tsao MS; Khokha R Lab Invest; 1999 Feb; 79(2):225-34. PubMed ID: 10068210 [TBL] [Abstract][Full Text] [Related]
49. Development of neuroepithelial tumors of the adrenal medulla in transgenic mice expressing a mouse hypothalamic growth hormone-releasing hormone promoter-simian virus-40 T-antigen fusion gene. Pecori Giraldi F; Mizobuchi M; Horowitz ZD; Downs TR; Aleppo G; Kier A; Wagner T; Yun JS; Kopchick JJ; Frohman LA Endocrinology; 1994 Mar; 134(3):1219-24. PubMed ID: 8119162 [TBL] [Abstract][Full Text] [Related]
50. Oval cell proliferation in early stages of hepatocarcinogenesis in simian virus 40 large T transgenic mice. Bennoun M; Rissel M; Engelhardt N; Guillouzo A; Briand P; Weber-Benarous A Am J Pathol; 1993 Nov; 143(5):1326-36. PubMed ID: 7694468 [TBL] [Abstract][Full Text] [Related]
51. Direct luteinizing hormone action triggers adrenocortical tumorigenesis in castrated mice transgenic for the murine inhibin alpha-subunit promoter/simian virus 40 T-antigen fusion gene. Rilianawati ; Paukku T; Kero J; Zhang FP; Rahman N; Kananen K; Huhtaniemi I Mol Endocrinol; 1998 Jun; 12(6):801-9. PubMed ID: 9626655 [TBL] [Abstract][Full Text] [Related]
52. Detection of activated c-H-ras oncogene in hepatocellular carcinomas developing in transgenic mice harboring albumin promoter-regulated simian virus 40 gene. Lee GH; Li H; Ohtake K; Nomura K; Hino O; Furuta Y; Aizawa S; Kitagawa T Carcinogenesis; 1990 Jul; 11(7):1145-8. PubMed ID: 2164892 [TBL] [Abstract][Full Text] [Related]
53. Immortalization of osteoclast precursors by targeting Bcl -XL and Simian virus 40 large T antigen to the osteoclast lineage in transgenic mice. Hentunen TA; Reddy SV; Boyce BF; Devlin R; Park HR; Chung H; Selander KS; Dallas M; Kurihara N; Galson DL; Goldring SR; Koop BA; Windle JJ; Roodman GD J Clin Invest; 1998 Jul; 102(1):88-97. PubMed ID: 9649561 [TBL] [Abstract][Full Text] [Related]
54. Inducible formation of liver tumors in transgenic mice. Rüther U; Woodroofe C; Fattori E; Ciliberto G Oncogene; 1993 Jan; 8(1):87-93. PubMed ID: 8423999 [TBL] [Abstract][Full Text] [Related]
55. Compensatory apoptosis in response to SV40 large T antigen expression in the liver. Allemand I; Grimber G; Kornprobst M; Bennoun M; Molina T; Briand P; Joulin V Oncogene; 1995 Dec; 11(12):2583-90. PubMed ID: 8545115 [TBL] [Abstract][Full Text] [Related]
56. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential. Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793 [TBL] [Abstract][Full Text] [Related]
57. Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen. Ewald D; Li M; Efrat S; Auer G; Wall RJ; Furth PA; Hennighausen L Science; 1996 Sep; 273(5280):1384-6. PubMed ID: 8703072 [TBL] [Abstract][Full Text] [Related]
58. Sex disparity in viral load, inflammation and liver damage in transgenic mice carrying full hepatitis B virus genome with the W4P mutation in the preS1 region. Lee SA; Lee SY; Choi YM; Kim H; Kim BJ World J Gastroenterol; 2018 Mar; 24(10):1084-1092. PubMed ID: 29563753 [TBL] [Abstract][Full Text] [Related]
59. Changes in the DNA methylation profile of the rat H19 gene upstream region during development and transgenic hepatocarcinogenesis and its role in the imprinted transcriptional regulation of the H19 gene. Manoharan H; Babcock K; Pitot HC Mol Carcinog; 2004 Sep; 41(1):1-16. PubMed ID: 15352122 [TBL] [Abstract][Full Text] [Related]
60. Experimental model for MDS-like myelodysplasia in transgenic mice harboring the SV40 large-T antigen under an immunoglobulin enhancer. Inoue T; Hirabayashi Y; Mitsui H; Furuta Y; Suda Y; Aizawa S; Ikawa Y Leukemia; 1994 Apr; 8 Suppl 1():S202-5. PubMed ID: 8152293 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]